University of California-Irvine — Orange, California

University of California-Irvine is a clinical research site located in Orange, California, United States 92868.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

University of California-Irvine has participated in 14 clinical trials with 3 currently active.

Therapeutic areas: Myasthenia Gravis, Cardiac Disease, Charcot-Marie-Tooth Disease.

Sponsors: Grifols Therapeutics LLC, Lantheus Medical Imaging, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California-Irvine?

University of California-Irvine has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California-Irvine conducted?

University of California-Irvine has 14 clinical trials on record, with 3 currently active. Their work covers Myasthenia Gravis, Cardiac Disease, Charcot-Marie-Tooth Disease.

Is University of California-Irvine accredited by Crixeo Health?

Yes — University of California-Irvine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of California-Irvine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.